We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Huntleigh Diagnostics

Featured Products: More products

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Huntleigh Presents Innovative Solutions in Vascular Care, Fetal and Patient Monitoring at MEDICA 2021

By HospiMedica International staff writers
Posted on 18 Nov 2021
Print article
Image: Huntleigh at MEDICA 2021 (Photo courtesy of Huntleigh Healthcare Ltd.)
Image: Huntleigh at MEDICA 2021 (Photo courtesy of Huntleigh Healthcare Ltd.)

Huntleigh Healthcare Ltd. (Wales, UK), a member of the Arjo family, presented its innovative solutions in vascular care, fetal and patient monitoring at MEDICA 2021.

MEDICA, the world's largest annual medical technology trade fair, took place from 15-18 November in Düsseldorf, Germany. At the 2021 edition of MEDICA, more than 5,000 exhibitors from 70 countries presented their newest products and ideas. The event also drew more than 120,000 trade visitors from over 170 countries. At MEDICA 2021, Huntleigh presented its Sonicaid Fetal Doppler product portfolio, which encompasses Sonicaid Digital SR2/SR3 2&3 MHz Waterproof Rate Display Dopplers, Sonicaid SRX Digital Doppler, Sonicaid D920/D930 Waterproof Audio Dopplers, and the Sonicaid FD1/FD3 2&3MHz Waterproof Dopplers.

These high sensitivity handheld Digital Dopplers are intended for general purpose screening of the fetal heart at all stages of pregnancy from as early as 8-10 weeks, right through to labor. The attached probes are waterproof (IPX7) for high sensitivity FHR detection in both normal use and in waterbirth monitoring. The high performance transducer enables reliable detection from early gestation right through to delivery, even on obese patients. In addition, Huntleigh displayed its new range of high sensitivity XS probes that have been designed, calibrated and fine-tuned to provide excellent performance over the widest gestational age and BMI range in all clinical settings.

Huntleigh also showcased its Smartsigns patient monitoring range which is capable of delivering a wide range of monitoring options, ranging from hand held or portable devices. Smartsigns patient monitors can be used to monitor the patient’s basic vital signs, through to advanced modular systems used in many low, medium & high acuity settings throughout all areas of healthcare. Huntleigh particularly highlighted its new SC500 Series vital signs monitor which comes with an integrated Early Warning scoring tool (MEWS & NEWS2), and three level alarms, making it ideal for long COVID measurements and observations.

Huntleigh’s extensive experience in vascular assessment was evident at MEDICA 2021, as the company showcased its technologically advanced range of products to improve the efficiency and effectiveness in vascular diagnosis. Huntleigh displayed its Dopplex Ability Automatic Automatic Ankle Brachial Index (ABI) System which has revolutionized the ABI process and provides automatic, easy, fast and accurate measurements with an immediate printout of results from the integral printer or optional DR4 software package. Also on display was the company’s entire vascular assessment Dopplers & kits product portfolio, including Dopplex D900, Dopplex SD2, Dopplex ABI Kit and Dopplex ATP Kit. Huntleigh also displayed its LymphAssist Professional 12 Chamber Intermittent Pneumatic Compression (IPC) System which has been designed to offer clinicians a multi modal treatment option to manage Lymphoedema and associated conditions.

Related Links:
Huntleigh Healthcare Ltd. 

Gold Supplier
Temperature Monitor
ThermoScan Temperature Monitoring Unit
New
Digital X-Ray Flat Panel Detector
2121DXV
New
Lesion Tracking Application
Sectra Lesion Tracking
New
Allograft
AXIOFILL

Print article
FIME - Informa

Channels

AI

view channel
Image: The AI tool can also tackle dangerous inequalities in heart attack diagnosis (Photo courtesy of Freepik)

AI Algorithm Integrates Cardiac Troponin Test Results with Clinical Data to Quickly Rule out Heart Attacks in Patients

The accepted standard for diagnosing myocardial infarction, or heart attack, involves assessing the blood for troponin levels. However, this approach applies the same benchmark for all patients, failing... Read more

Critical Care

view channel
Image: New technology gives patients the power to heal chronic wounds using their own blood (Photo courtesy of RedDress)

POC Solution Creates In Vitro Blood Clots from Patient’s Own Whole Blood in Real-Time to Treat Post-Surgical Wounds

Blood clots are a natural mechanism of the body's healing process. However, for chronic wounds resulting from diabetes and other conditions, blood is unable to reach these areas, hampering the initiation... Read more

Surgical Techniques

view channel
Image: The deployable electrodes are ideal for minimally invasive craniosurgery (Photo courtesy of EPFL)

Soft Robotic Electrode Offers Minimally Invasive Solution for Craniosurgery

Minimally invasive medical procedures offer numerous benefits to patients, including decreased tissue damage and shorter recovery periods. However, creating equipment that can pass through a small opening... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: IntelliSep is the first FDA-cleared diagnostic tool to assess cellular host response to aid in identifying ED patients with sepsis (Photo courtesy of Cytovale)

Rapid Microfluidic Test Demonstrates Efficacy as Diagnostic Aid to Improve Sepsis Triage in ED

Sepsis is the primary cause of mortality worldwide, accounting for over 350,000 fatalities annually in the United States alone, a figure that surpasses deaths from opioid overdoses, prostate cancer, and... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.